Objective:To observe the efficacy of Firebird drug-eluting stent in patients with type 2 diabetes and coronary heart disease. Method:90 patients with type 2 diabetes and coronary heart disease from March 2005 to December 2006 were enrolled to have the treatment of percutaneous coronary invention

47 in Domestic Firebird Stent group and 43 in Bare Stent group. All patients were administered asprin and Clopidogrel regularly before and after procedures

meanwhile

medical treatment was used strongly and strictly. Followed up the patients after PCI

observed the major adverse cardiac events(MACE)

and compared the efficacy between the two groups. Results:Coronary angiographic(CAG) showed that the patients with more than 2 lesion coronaries take 71.11 % of all.74 Firebird Stents were implanted in Firebird group and 55 Bare Stents were implanted in Bare metal stents group.Each patient has got an successful operation. Mean follow-up duration was 10.2±3.3 months after stent implanting. 3 patients suffered angina pectoris reoccurrence and 2 suffered major adverse cardiac events(MACE) in Firebird Stent group

while 13 patients suffered angina pectoris reoccurrence and 13 suffered MACE in Bare metal stent group. Rate of angina pectoris reoccurrence and MACE occurrence in Firebird Stent group were much lower than that of in Bare metal stent group

there was significant difference between the two groups(6.4% vs 30.2%

P<0.01;4.2% vs 30.2%

P<0.01).Some patients in each group had got CAG recheck. 1 patients suffered restenosis in Firebird Stent group and7 in Bare Stent group

there was no significant difference between the two groups(P>0.05). Conclusion:Firebird stent in patients with type 2 diabetes and coronary heart disease has a definite clinical efficacy

which can reduce the occurrence of MACEs.